Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy
Rohit Hariharan, Mark Jenkins
BMJ OPEN GASTROENTEROLOGY | BMJ PUBLISHING GROUP | Published : 2020
Background: Circulating tumour DNA from colorectal cancer (CRC) is a biomarker for early detection of the disease and therefore potentially useful for screening. One such biomarker is the methylated SEPT9 (mSEPT9) gene, which occurs during CRC tumourigenesis. This systematic review and meta-analysis aims to establish the sensitivity, specificity and accuracy of mSEPT9 tests for the early diagnosis of CRC. Methods: A systematic search of the relevant literature was conducted using Medline and Embase databases. Data were extracted from the eligible studies and analysed to estimate pooled sensitivity, specificity and diagnostic test accuracy. Results: Based on 19 studies, the pooled estimates (..View full abstract
Related Projects (1)
Awarded by National Health and Medical Research Council
This study was funded by National Health and Medical Research Council (Grant number: APP1117611).